Apricus Biosciences (APRI) Reports Q4 Loss of $0.04/Share

Apricus Biosciences (NASDAQ: APRI) reported Q4 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $400 thousand, versus $2.6 million reported last year.

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79